Hologic
Hologic, Inc., a leading global medical technology company headquartered in the United States, has been at the forefront of women's health since its founding in 1982. With a strong presence in North America, Europe, and Asia, Hologic focuses on innovative solutions in the fields of diagnostics, medical imaging, and surgical products. Renowned for its advanced technologies, Hologic's core offerings include breast health, gynaecological health, and skeletal health solutions, which are distinguished by their precision and efficacy. The company has achieved significant milestones, including pioneering developments in 3D mammography and molecular diagnostics, solidifying its position as a market leader. Hologic's commitment to improving patient outcomes and enhancing healthcare efficiency has earned it numerous accolades, making it a trusted name in the medical technology industry.
DitchCarbon Score
How does Hologic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hologic's score of 33 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hologic's reported carbon emissions
In 2023, Hologic, headquartered in the US, reported total carbon emissions of approximately 19,244,000 kg CO2e, comprising 7,056,000 kg CO2e from Scope 1 and 12,188,000 kg CO2e from Scope 2 emissions. This marks a significant reduction from previous years, reflecting the company's commitment to sustainability. Over the years, Hologic has demonstrated a consistent effort to lower its carbon footprint. For instance, in 2022, the total emissions were about 19,897,000 kg CO2e, indicating a downward trend. The company has set near-term targets for emissions reduction, although it has not yet committed to a net-zero target. Hologic's emissions data highlights its focus on reducing Scope 1 and Scope 2 emissions, which are directly related to its operations and energy consumption. The healthcare equipment and supplies sector is increasingly prioritising climate action, and Hologic's initiatives align with this industry-wide movement towards sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 3,500,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 19,496,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hologic is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
